Molecular profiling studies of HCC have identified key oncogenic pathways [9]—RTK/RAS, TGF-beta, WNT, PI3K/AKT, and TP53—that play critical roles in tumor initiation, progression, and therapeutic resistance. The gene discussed is TP53; the disease is neoplasm.